title: Retracted: Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566.
abstract: Retraction: "Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566" by R. M. J. Deacon, M. J. Hurley, C. M. Rebolledo, M. Snape, F. J. Altimiras, L. Farías, M. Pino, R. Biekofsky, L. Glass and P. Cogram. The above article, from Genes, Brain and Behavior, published online on 12th May 2017 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor in Chief, Andrew Holmes and John Wiley & Sons Ltd. The retraction has been agreed as all authors cannot agree on a revised author order, and at least one author continues to dispute the original order. In this case, the original article is being retracted on the grounds that the journal does not have permission to publish. Reference: Deacon, R. M. J., Hurley, M. J., Rebolledo, C. M., Snape, M., Altimiras, F. J., Farías, L., Pino, M., Biekofsky, R., Glass, L. and Cogram, P. (2017), Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566. Genes, Brain and Behavior. doi:10.1111/gbb.12373.
authors.affiliation: Biomedicine Division, Centre for Systems Biotechnology, Fraunhofer Research Foundation, Santiago, Chile.|Gen.DDI Ltd, London, UK.|Laboratory of Molecular Neuropsychiatry, Institute of Cognitive and Translational Neuroscience (INCyT), INECO Foundation, Favaloro University, National Scientific and Technical Research Council, Buenos Aires, Argentina.
authors.forename: R M J
authors.initials: RMJ
authors.lastname: Deacon
authors.affiliation: Laboratory of Molecular Neuropsychiatry, Institute of Cognitive and Translational Neuroscience (INCyT), INECO Foundation, Favaloro University, National Scientific and Technical Research Council, Buenos Aires, Argentina.|Division of Brain Sciences, Centre for Neuroinflammation and Neurodegeneration, Imperial College, London, UK.
authors.forename: M J
authors.initials: MJ
authors.lastname: Hurley
authors.affiliation: Facultad de Ciencias, Universidad de Chile, Santiago, Chile.
authors.forename: C M
authors.initials: CM
authors.lastname: Rebolledo
authors.affiliation: AMO Pharmaceuticals Ltd, Huntingdon, UK.
authors.forename: M
authors.initials: M
authors.lastname: Snape
authors.affiliation: Biomedicine Division, Centre for Systems Biotechnology, Fraunhofer Research Foundation, Santiago, Chile.|Facultad de Ingeniería y Ciencias, Universidad Adolfo Ibañez, Santiago, Chile.
authors.forename: F J
authors.initials: FJ
authors.lastname: Altimiras
authors.affiliation: Biomedicine Division, Centre for Systems Biotechnology, Fraunhofer Research Foundation, Santiago, Chile.|Facultad de Ingeniería y Ciencias, Universidad Adolfo Ibañez, Santiago, Chile.
authors.forename: L
authors.initials: L
authors.lastname: Farías
authors.affiliation: Biomedicine Division, Centre for Systems Biotechnology, Fraunhofer Research Foundation, Santiago, Chile.
authors.forename: M
authors.identifier: 0000-0002-1773-6327
authors.initials: M
authors.lastname: Pino
authors.affiliation: Neuro-DVI LLP, London, UK.
authors.forename: R
authors.initials: R
authors.lastname: Biekofsky
authors.affiliation: Neuren Pharmaceuticals, Bethesda, MD, USA.
authors.forename: L
authors.initials: L
authors.lastname: Glass
authors.affiliation: Biomedicine Division, Centre for Systems Biotechnology, Fraunhofer Research Foundation, Santiago, Chile.|Laboratory of Molecular Neuropsychiatry, Institute of Cognitive and Translational Neuroscience (INCyT), INECO Foundation, Favaloro University, National Scientific and Technical Research Council, Buenos Aires, Argentina.|Institute Of Ecology and Biodiversity (IEB), Faculty of Science, University of Chile, Santiago, Chile.
authors.forename: P
authors.identifier: 0000-0002-4198-0821
authors.initials: P
authors.lastname: Cogram